Exploring Fatty Acid Mimetics as NR4A Ligands.
Stiller T, Merk D.
J Med Chem · research support, non-u.s. gov't; research-article; journal article · DOI 10.1021/acs.jmedchem.3c01467 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för vidofludimus. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
11 träffarDiscovery and Optimization of Novel <i>h</i>DHODH Inhibitors for the Treatment of Inflammatory Bowel Disease.
Zhou X, Gou K, Xu J, Jian L, Luo Y, Li C, Guan X, Qiu J, Zou J, Zhang Y, Zhong X, Zeng T, Zhou Y, Xiao Y, Yang X, Chen W, Gao P, Liu C, Zhou Y, Tao L, Liu X, Cen X, Chen Q, Sun Q, Luo Y, Zhao Y.
J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jmedchem.3c01365<i>De Novo</i> Design of Nurr1 Agonists <i>via</i> Fragment-Augmented Generative Deep Learning in Low-Data Regime.
Ballarotto M, Willems S, Stiller T, Nawa F, Marschner JA, Grisoni F, Merk D.
J Med Chem · research support, non-u.s. gov't; research-article; journal article · DOI 10.1021/acs.jmedchem.3c00485Development of a Potent Nurr1 Agonist Tool for In Vivo Applications.
Vietor J, Gege C, Stiller T, Busch R, Schallmayer E, Kohlhof H, Höfner G, Pabel J, Marschner JA, Merk D.
J Med Chem · research support, non-u.s. gov't; research-article; journal article · DOI 10.1021/acs.jmedchem.3c00415The activity and mechanism of vidofludimus as a potent enzyme inhibitor against NDM-1-positive E. coli.
Li X, Zhao D, Zhao X, Cheng P, Li F, Sun J, Li Y, Bai J, Zhang X.
Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2023.115225Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives.
Zhang L, Zhang J, Wang J, Ren C, Tang P, Ouyang L, Wang Y.
Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2022.114176Recent Advances in the Medicinal Chemistry of Farnesoid X Receptor.
Fang Y, Hegazy L, Finck BN, Elgendy B.
J Med Chem · review; journal article · DOI 10.1021/acs.jmedchem.1c01017Discovery of JMJD7 inhibitors with the aid of virtual screening and bioactivity evaluation.
Zhang W, Li K, Wang T, Wu M, Li L.
Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2021.128139Cerpegin-derived furo[3,4-c]pyridine-3,4(1H,5H)-diones enhance cellular response to interferons by de novo pyrimidine biosynthesis inhibition.
Hayek S, Pietrancosta N, Hovhannisyan AA, Alves de Sousa R, Bekaddour N, Ermellino L, Tramontano E, Arnould S, Sardet C, Dairou J, Diaz O, Lotteau V, Nisole S, Melikyan G, Herbeuval JP, Vidalain PO.
Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2019.111855SAR, species specificity, and cellular activity of cyclopentene dicarboxylic acid amides as DHODH inhibitors.
Leban J, Kralik M, Mies J, Gassen M, Tentschert K, Baumgartner R.
Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2005.07.053Biphenyl-4-ylcarbamoyl thiophene carboxylic acids as potent DHODH inhibitors.
Leban J, Kralik M, Mies J, Baumgartner R, Gassen M, Tasler S.
Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2005.10.011